What does this research mean for the field?

Although CRP and hsCRP demonstrate the strongest clinical evidence as inflammatory biomarkers for prediabetes, current evidence does not support using any inflammatory marker as a standalone diagnostic test. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

Synthesize mechanistic and clinical evidence on the inflammatory landscape of prediabetes, evaluate candidate biomarkers, and assess their readiness for clinical risk prediction.

September 8, 2026DiabetologyOpen Access

Potential Biomarkers for the Early Prediction of Prediabetes

View Full Paper

Ask AI

Bookmark

Authors

LMLuisa V. Gracia Mazuca BMBibiana Mancera

Discussion

Member takes

Overview

Narrative review reveals elevated CRP and inflammatory markers across prediabetic cohorts, indicating potential for risk stratification but insufficient evidence for standalone diagnosis.

Key Points

Synthesize mechanistic and clinical evidence on the inflammatory landscape of prediabetes, evaluate candidate biomarkers, and assess their readiness for clinical risk prediction.
Conducted a structured narrative review analyzing 22 studies spanning animal models, human pancreatic islets, and clinical cohorts.
Evaluated candidate biomarkers including cytokines, oxidative stress indicators, microRNAs, and immune-cell factors across cross-sectional, longitudinal, and mechanistic designs.
C-reactive protein (CRP) and high-sensitivity CRP (hsCRP) demonstrated the strongest translational evidence, with elevated baseline levels consistently tied to increased risk of progression to type 2 diabetes.
Other candidates, including IL-6, TNF-α, adiponectin, SFRP4, microRNAs, and oxidative stress indicators, displayed promising but heterogeneous and inconsistent associations across cohorts.
Current clinical evidence does not support any inflammatory marker as an independent, standalone diagnostic test for prediabetes.

Cite This Study

Mazuca et al. (2026) studied this question.

synapsesocial.com/papers/6a9fd83b58e84d0ff5b47a55 https://doi.org/10.3390/diabetology7090174

View Full Paper

Ask AI

Bookmark

September 8, 2026DiabetologyOpen Access

Potential Biomarkers for the Early Prediction of Prediabetes

View Full Paper

Ask AI

Bookmark

Authors

LMLuisa V. Gracia Mazuca BMBibiana Mancera

Discussion

Member takes

Overview

Narrative review reveals elevated CRP and inflammatory markers across prediabetic cohorts, indicating potential for risk stratification but insufficient evidence for standalone diagnosis.

Key Points

Synthesize mechanistic and clinical evidence on the inflammatory landscape of prediabetes, evaluate candidate biomarkers, and assess their readiness for clinical risk prediction.
Conducted a structured narrative review analyzing 22 studies spanning animal models, human pancreatic islets, and clinical cohorts.
Evaluated candidate biomarkers including cytokines, oxidative stress indicators, microRNAs, and immune-cell factors across cross-sectional, longitudinal, and mechanistic designs.
C-reactive protein (CRP) and high-sensitivity CRP (hsCRP) demonstrated the strongest translational evidence, with elevated baseline levels consistently tied to increased risk of progression to type 2 diabetes.
Other candidates, including IL-6, TNF-α, adiponectin, SFRP4, microRNAs, and oxidative stress indicators, displayed promising but heterogeneous and inconsistent associations across cohorts.
Current clinical evidence does not support any inflammatory marker as an independent, standalone diagnostic test for prediabetes.

Cite This Study

Mazuca et al. (2026) studied this question.

synapsesocial.com/papers/6a9fd83b58e84d0ff5b47a55 https://doi.org/10.3390/diabetology7090174

View Full Paper

Ask AI

Bookmark